Bilateral Pecto Intercostal Fascial Plane Block After Open Heart Surgeries

Overview

The objective is to test the effect of pecto intercostal fascial plane block (PIFB) as regard its impact on pain after sternotomy involved open heart surgery. The authors hypothesize that bilateral PIFB can reduce pain resulting from sternotomy following open heart surgeries.

Full Title of Study: “The Analgesic Effect of Ultrasound Guided Bilateral Pecto Intercostal Fascial Plane Block on Sternal Wound Pain After Open Heart Surgeries”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Prevention
    • Masking: Triple (Participant, Investigator, Outcomes Assessor)
  • Study Primary Completion Date: November 1, 2020

Detailed Description

Pain following cardiac surgery is caused by many factors; sternotomy, chest wall retraction, opening of the pericardium, internal mammarian artery harvesting, saphenous vein harvesting, surgical manipulation of the parietal pleura, chest tube insertion and other musculoskeletal trauma occurring during surgery. The pain following cardiac surgery is mainly attributed to sternotomy, with its peak during the first two days after the operation. Poststernotomy pain is not well tolerated by patients and may be accompanied by adverse postoperative events including delirium, hypertension, tachycardia, arrhythmia, respiratory complications, and persistent postsurgical pain. Commonly pain management after cardiac surgery has been achieved using opiate analgesics. However, opiates have some dose-related side-effects such as nausea, constipation, vomiting, dizziness, mental confusion and respiratory depression, which may influence patient recovery and may delay discharge after surgery. The pecto-intercostal fascial block (PIFB) was recently introduced by de la Torre et al for anesthesia during breast surgery. Local anesthetic is infiltrated into the interfascial plane separating pectoralis major and the intercostal muscles lateral to the sternum to anesthetize the anterior cutaneous branches of the intercostal nerves. The pecto-intercostal fascial plane block can cover anterior branches of the intercostal nerves from the 2nd to 6th dermatomes with a single injection bilaterally, same as the transversus thoracic muscle plane block . anesthetic management: All patients will be preoperatively examined and investigated by complete blood count, coagulation profile, renal and kidney functions and electrolytes. Electrocardiography, chest x ray and echocardiography will be routinely done. Coronary angiography and carotid arterial duplex will be requested in patients prepared for CABG. Patient will be premedicated by intramuscular injection of 10mg morphine in the morning of the operation. Before induction of anesthesia, a five-lead electrocardiography system will be applied to monitor heart rate, rhythm, and ST segments (leads II and V5). A pulse oximeter probe will be attached, and a peripheral venous cannula will be placed. For measurement of arterial pressure and blood sampling, a 20 G cannula will be inserted into either right or left radial artery under local anesthesia. General anesthesia will be induced by midazolam 2-5 mg, fentanyl (10 μg/kg), propofol (3-4mg/Kg), followed by atracurium (0.5 mg/kg). Trachea will be intubated, patients will be mechanically ventilated with oxygen in air so as to achieve normocarbia. This will be confirmed by radial arterial blood gas analysis. An esophageal temperature probe and a Foley catheter will also be placed. For drug infusion, a triple-lumen central venous catheter will be inserted via the right internal jugular vein. Anesthesia will be maintained by inhaled Isoflurane 0.4 to 1% and atracurium infusion at a rate of 0.5 mg/kg/h for continued muscle relaxation. During extracorporeal circulation, patients will receive propofol infusion at a rate of 100-200 mg/h in addition to atracurium infusion. Before initiation of cardiopulmonary bypass (CPB), the patients will receive intravenously tranexamic acid (2 g) and heparin (300-500 units/kg body weight) to achieve an activated clotting time > 480 s. CPB will be instituted via an ascending aortic cannula and a two-stage right atrial cannula. Before, during, and after CPB (pump blood flow: 2.4 l/min/m2), mean arterial pressure will be adjusted to exceed 60 mmHg. Cardiac arrest will be induced with cold antegrade blood cardioplegia or warm intermittent antegrade crystalloid cardioplegia. Lactate-enriched Ringer's solution will be added to the CPB circuit to maintain reservoir volume when needed, and packed red blood cells will be added when hemoglobin concentration decrease to less than 7 g/dl. After rewarming the patient to 37°C and separation from CPB, reversal of heparin by protamine sulfate (1:1), and sternal closure will be achieved. All patients then will be shifted to the intensive care unit (ICU) after the surgery and managed with the institution's ICU protocol for postoperative pain management and ventilation. The postoperative analgesia protocol involves the use of intravenous morphine or morphine equivalent dose of 5to 10 mg/kg bolus as required. Criteria for administration will be signs of sympathetic stimulation in the form of undue tachycardia, a rise in mean arterial pressure (rise of >20% from the baseline). Tracheal extubation will be performed when the patient met the following criteria: awake/arousable, hemodynamically stable, no active bleeding, warm peripheries, and satisfactory arterial blood gas with an FiO2 < 0.5,pressure support on ventilator reduced to 10 Cm H2O,Positive End Expiratory Pressure 5-7 CmH2O, no electrolyte abnormalities, minimal inotropic support, or no escalation in inotropic support. Statistical analysis Sample size was calculated using (G power version 3). Minimal sample size of patients was 31 in each group needed to get power level 0.90, alpha level 0.05 and 30% as a difference between the two groups in the morphine consumption after the intervention. To overcome problem of loss of follow up, calculated sample size was increased by 10% to reach 35 in each group.

Interventions

  • Device: ultrasound
    • in the PIFB group linear ultrasound (Philips clear vue350,Philips healthcare,Andover MAO1810,USA,Machine Identification number:1385,Nile medical center,service@nilemed.net) probe will be used.
  • Drug: Bupivacaine Hydrochloride 5 MG/ML
    • twenty milliliters of a solution of 0.25% bupivacaine in the PIFB group

Arms, Groups and Cohorts

  • Experimental: PIFB group
    • For carrying out PIFB bilaterally the skin on either side of the sternum will be prepared with povidone iodine solution. Then a linear ultrasound probe will be placed on the right and left sides at 2 cm from the sternal body. A 22 gauge, 4 inch needle will be advanced until contacting the 4th costal cartilage following the lower edge of US probe, directing the tip from the bottom of the sternum and positioning the needle tip between the pectoralis major and the external intercostal muscles. Group A will receive twenty milliliters of a solution of 0.25% bupivacaine plus epinephrine (5 mcg/ml). Boluses of 5 ml are introduced to perform hydrodissection of the interfascial plane.
  • No Intervention: control group
    • the block will not be given

Clinical Trial Outcome Measures

Primary Measures

  • Cumulative morphine consumption
    • Time Frame: 24 hours postoperative
    • in milligram

Secondary Measures

  • postoperative sternal wound pain degree
    • Time Frame: 4 hours after extubation
    • Objective pain score (1:pain at rest , 2:Pain free at rest, 3:Pain free when deep breathing, but pain when coughing, 4:Pain free, even when coughing 1 (worst) to 4 (best) not summed
  • postoperative sternal wound pain degree
    • Time Frame: 8 hours after extubation
    • Objective pain score (1:pain at rest , 2:Pain free at rest, 3:Pain free when deep breathing, but pain when coughing, 4:Pain free, even when coughing 1 (worst) to 4 (best) not summed
  • postoperative sternal wound pain degree
    • Time Frame: 12 hours after extubation
    • Objective pain score (1:pain at rest , 2:Pain free at rest, 3:Pain free when deep breathing, but pain when coughing, 4:Pain free, even when coughing 1 (worst) to 4 (best) not summed
  • postoperative sternal wound pain degree
    • Time Frame: 16 hours after extubation
    • Objective pain score (1:pain at rest , 2:Pain free at rest, 3:Pain free when deep breathing, but pain when coughing, 4:Pain free, even when coughing 1 (worst) to 4 (best) not summed
  • postoperative sternal wound pain degree
    • Time Frame: 20 hours after extubation
    • Objective pain score (1:pain at rest , 2:Pain free at rest, 3:Pain free when deep breathing, but pain when coughing, 4:Pain free, even when coughing 1 (worst) to 4 (best) not summed
  • postoperative sternal wound pain degree
    • Time Frame: 24 hours after extubation
    • Objective pain score (1:pain at rest , 2:Pain free at rest, 3:Pain free when deep breathing, but pain when coughing, 4:Pain free, even when coughing 1 (worst) to 4 (best) not summed
  • Heart rate
    • Time Frame: 1 minute before induction of anesthesia, 5 minutes after induction of anesthesia then every 30 minutes for 8 times
    • in beat per minute
  • systolic blood pressure
    • Time Frame: 1 minute before induction of anesthesia, 5 minutes after induction of anesthesia then every 30 minutes for 8 times
    • in millimeter mercury
  • diastolic blood pressure
    • Time Frame: 1 minute before induction of anesthesia, 5 minutes after induction of anesthesia then every 30 minutes for 8 times
    • in millimeter mercury
  • peripheral oxygen saturation
    • Time Frame: 1 minute before induction of anesthesia, 5 minutes after induction of anesthesia then every 30 minutes for 8 times
    • in percentage by pulse oximetry
  • heart rate
    • Time Frame: 1 minute after admission in ICU then every 4 hours for 6 times then every 8 hours for 3 times
    • in beat per minute
  • systolic blood pressure
    • Time Frame: 1 minute after admission in ICU then every 4 hours for 6 times then every 8 hours for 3 times
    • in millimeter mercury
  • diastolic blood pressure
    • Time Frame: 1 minute after admission in ICU then every 4 hours for 6 times then every 8 hours for 3 times
    • in millimeter mercury
  • peripheral oxygen saturation
    • Time Frame: 1 minute after admission in ICU then every 4 hours for 6 times then every 8 hours for 3 times
    • in percentage by pulse oximetry
  • incidence of Myocardial infarction
    • Time Frame: 1 minute after ICU admission
    • number
  • incidence of postoperative pericardial effusion
    • Time Frame: 1 minute after ICU admission
    • number
  • incidence of heart failure requiring inotropic support
    • Time Frame: 1 minute after ICU admission
    • number
  • incidence of atrial fibrillation
    • Time Frame: 1 minute after ICU admission
    • number
  • partial pressure of oxygen
    • Time Frame: 1 minute after insertion of arterial cannula
    • by mmhg in arterial blood gases
  • partial pressure of oxygen
    • Time Frame: 1 minute after extubation
    • by mmhg in arterial blood gases
  • partial pressure of oxygen
    • Time Frame: 6 hour after extubation
    • by mmhg in arterial blood gases
  • partial pressure of oxygen
    • Time Frame: 12 hour after extubation
    • by mmhg in arterial blood gases
  • incidence of cerebral stroke
    • Time Frame: 1 minute after ICU admission up to 2 days
    • number
  • incidence of cerebral bleeding
    • Time Frame: 1 minute after ICU admission up to 2 days
    • number
  • Gastrointestinal bleeding
    • Time Frame: 1 minute after ICU admission up to 2 days
    • number
  • blood component requirements
    • Time Frame: 1 minute after ICU admission up to 2 days
    • number
  • incidence of sternal complications.
    • Time Frame: 1 minute after ICU admission up to 2 days
    • number
  • hospital stay
    • Time Frame: 1 minute after ICU admission up to 2 days
    • in days

Participating in This Clinical Trial

Inclusion Criteria

  • Patients scheduled for elective cardiovascular surgery for coronary artery bypass grafting or valve replacement involving median sternotomy Exclusion Criteria:

  • Patients with emergency surgeries. – Allergy to drug used. – Patients with prolonged Cardio-Pulmonary Bypass time (>120 min). – Preoperative poor left ventricular function (ejection fraction <40%). – Body Mass Index >40. – Systemic infections or infections at site of injection. – Prolonged ICU stay over 24 hours for different reasons i.e.re-do surgery, heart failure etc.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Fayoum University Hospital
  • Provider of Information About this Clinical Study
    • Principal Investigator: Mohamed Ahmed Hamed, lecturer of anesthesia and intensive care – Fayoum University Hospital
  • Overall Official(s)
    • Maged L Boules, MD, Study Chair, Faculty of medicine, Fayoum university
    • Mohamed A Hamed, MD, Study Director, Faculty of medicine, Fayoum university

References

Huang AP, Sakata RK. [Pain after sternotomy – review]. Rev Bras Anestesiol. 2016 Jul-Aug;66(4):395-401. doi: 10.1016/j.bjan.2014.09.003. Epub 2015 Mar 18. Portuguese.

Mazzeffi M, Khelemsky Y. Poststernotomy pain: a clinical review. J Cardiothorac Vasc Anesth. 2011 Dec;25(6):1163-78. doi: 10.1053/j.jvca.2011.08.001. Epub 2011 Sep 29. No abstract available.

Chandrakantan A, Glass PS. Multimodal therapies for postoperative nausea and vomiting, and pain. Br J Anaesth. 2011 Dec;107 Suppl 1:i27-40. doi: 10.1093/bja/aer358.

Del Buono R, Costa F, Agro FE. Parasternal, Pecto-intercostal, Pecs, and Transverse Thoracic Muscle Plane Blocks: A Rose by Any Other Name Would Smell as Sweet. Reg Anesth Pain Med. 2016 Nov/Dec;41(6):791-792. doi: 10.1097/AAP.0000000000000464. No abstract available.

Ohgoshi Y, Ino K, Matsukawa M. Ultrasound-guided parasternal intercostal nerve block. J Anesth. 2016 Oct;30(5):916. doi: 10.1007/s00540-016-2202-5. Epub 2016 Jun 20. No abstract available.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.